M O Favorov

Author PubWeight™ 29.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis 1997 1.79
2 Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001 1.73
3 Epitope mapping in proteins of hepatitis E virus. Virology 1993 1.25
4 Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology 1994 1.22
5 Aetiology of acute sporadic non-A, non-B viral hepatitis in India. J Med Virol 1993 1.08
6 Progress toward tuberculosis control and determinants of treatment outcomes--Kazakhstan, 2000-2002. MMWR Morb Mortal Wkly Rep 2006 0.99
7 Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. Am J Epidemiol 2005 0.96
8 Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection. J Infect Dis 1997 0.92
9 Serological evidence for hepatitis E virus infection in Israel. J Med Virol 1995 0.90
10 Viral hepatitis serological markers among pregnant women in Caracas, Venezuela: implication for perinatal transmission of hepatitis B and C. G E N 1994 0.87
11 Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol 1994 0.86
12 Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch Virol 2000 0.86
13 The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity. Epidemiol Infect 2005 0.86
14 A small open reading frame of the hepatitis delta virus antigenomic RNA encodes a protein that elicits antibodies in some infected patients. Virus Res 1993 0.83
15 Hepatitis E virus infection in hemophiliacs. J Med Virol 1995 0.83
16 Hepatitis E in a U.S. traveler to Mexico. N Engl J Med 1991 0.83
17 Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J Virol 1994 0.82
18 Serological survey of markers of infection with viral hepatitis among the Yukpa Amerindians from western Venezuela. Ann Trop Med Parasitol 1996 0.82
19 Hepatitis E seroprevalence in selected individuals in South Africa. J Med Virol 1994 0.82
20 Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV. Acta Virol 1993 0.81
21 Nucleotide sequences in human chromosomal DNA from nonhepatic tissues homologous to the hepatitis B virus genome. Gene 1985 0.80
22 [The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity]. Vopr Virusol 1993 0.79
23 Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India. J Viral Hepat 1995 0.79
24 Universal immunization: the diphtheria control strategy of choice in the Republic of Tajikistan, 1993-1997. J Infect Dis 2000 0.78
25 Synthetic gene for the hepatitis C virus nucleocapsid protein. Nucleic Acids Res 1993 0.78
26 [Prevalence of hepatitis E virus antibodies in pregnant women in the Paris region: serological considerations]. Presse Med 1995 0.78
27 [Clinico-epidemiological characteristics and diagnosis of viral non-A, non-B hepatitis with fecal and oral mechanisms of transmission of the infection]. Vopr Virusol 1986 0.77
28 [Characteristics of viral hepatitis non-A, non-B with a fecal-oral mechanism of transmission of the infection in southern Uzbekistan]. Vopr Virusol 1989 0.77
29 [Morbidity and mortality in acute viral hepatitides in a hyperendemic region. The role of viral hepatitis E]. Zh Mikrobiol Epidemiol Immunobiol 2000 0.76
30 [The incidence of detecting hepatitis C viral antibodies in different age groups of the population in northeastern Ukraine]. Vopr Virusol 1994 0.76
31 [A comparative study of enteral hepatitis E (non-A, non-B) in the valley and mountainous areas of Kirghizia]. Vopr Virusol 1991 0.75
32 [Synthesis and antigenic activity of peptides from the ORF3 protein sequence of hepatitis E virus]. Bioorg Khim 1995 0.75
33 [Subtypes of HBsAg of the hepatitis B virus in Western Siberia]. Vopr Virusol 2004 0.75
34 [Detection of tuberculosis in the countries of Central Asia by the electronic monitoring system data]. Probl Tuberk Bolezn Legk 2008 0.75
35 Populations with high prevalence of antibody against hepatitis E virus in Israel. Clin Diagn Virol 1996 0.75
36 [Various physico-chemical properties of non-A, non-B hepatitis virus with a fecal-oral route of transmission and specific diagnosis of the illness]. Vopr Virusol 1989 0.75
37 [Synthesis and immunological properties of the peptide fragment of the hepatitis B virus envelope preS-protein]. Bioorg Khim 1990 0.75
38 [Electron microscopic research in non-A, non-B viral hepatitis with a fecal-oral mechanism of infection transmission]. Vopr Virusol 1986 0.75
39 [Specific safety and immunogenicity of a subunit vaccine against hepatitis B]. Vopr Virusol 1985 0.75
40 [Non-A, non-B hepatitis]. Zh Mikrobiol Epidemiol Immunobiol 1981 0.75
41 [The characteristics of an outbreak of non-A, non-B hepatitis with a fecal-oral mechanism of the transmission of the causative agent in Osh Province, the Kirghiz SSR]. Zh Mikrobiol Epidemiol Immunobiol 1990 0.75
42 [The quality of laboratory diagnosis of viral hepatitis and analysis of factors affecting the reliability of results]. Klin Lab Diagn 2001 0.75
43 [Post-transfusion hepatitis in patients after heart surgery]. Gematol Transfuziol 1985 0.75
44 [Non-A, non-B hepatitis: a new form of serum hepatitis]. Vopr Virusol 1981 0.75
45 [Value of IgM and IgG class anti-HBs in the differential diagnosis of viral hepatitis B and "non-A, non-B"]. Vopr Virusol 1982 0.75
46 [The etiological structure of acute viral hepatitis in Tadzhikistan in a period of decreased morbidity]. Vopr Virusol 1992 0.75
47 [Modern methods of the diagnosis of serum hepatitis type B]. Sov Med 1979 0.75
48 [Characteristics of the course and outcome of viral hepatitis A in patients treated at home]. Ter Arkh 1989 0.75
49 [Detection of antibodies to HIV virus in saliva by express-tests in Uzbekistan]. Klin Lab Diagn 2004 0.75
50 [Morphological changes in the hepatocytes in viral non-A, non-B hepatitis]. Vopr Virusol 1986 0.75
51 [Results of development and introduction of programs for quality control of laboratory diagnostics of infection diseases in Central Asia]. Klin Lab Diagn 2005 0.75
52 [Clinical course and outcome of acute hepatitis B in relation to the markers of the E system]. Ross Med Zh 1992 0.75
53 [The results of a controlled field trial of a dried erythrocytic immunoglobulin diagnostic agent for detecting the hepatitis A virus antigen]. Zh Mikrobiol Epidemiol Immunobiol 1991 0.75
54 [The results of training laboratory experts from Central Asia in ensuring the quality control in the HIV diagnostics]. Klin Lab Diagn 2005 0.75
55 [The clinical picture and outcome of acute delta infection]. Klin Med (Mosk) 1992 0.75
56 [Clinical picture and outcomes of post-transfusion viral hepatitis non-A, non-B and B]. Sov Med 1985 0.75
57 [Improvements in the laboratory diagnosis of hemorrhagic fever with a renal syndrome]. Vopr Virusol 1982 0.75
58 [Further study of viral non-A, non-B hepatitis]. Vopr Virusol 1986 0.75
59 Artificial mosaic proteins as new immunodiagnostic reagents: the hepatitis E virus experience. Clin Diagn Virol 1996 0.75
60 [Viral hepatitis C]. Vopr Virusol 1992 0.75
61 [The structure of viral hepatitis in the Socialist Republic of Vietnam]. Vopr Virusol 1991 0.75
62 [An educational module for organization of a system for controlling quality of laboratory diagnosis of infections for the Central Asia regions]. Klin Lab Diagn 2002 0.75
63 [A comparative study of non-A, non-B hepatitis with a fecal-oral mechanism of the transmission of the causative agent in the USSR and India]. Vopr Virusol 1991 0.75
64 [Combined infection with hepatitis viruses B and non-A, non-B]. Sov Med 1986 0.75
65 [Non-A, non-B viral hepatitis--study problems]. Vopr Virusol 1984 0.75
66 [The production of anti-HBc IgM antibodies by human lymphocytes transformed by the Epstein-Barr virus]. Vopr Virusol 1991 0.75
67 [A comparative study of the diagnostic value of peptides, corresponding to various genomic sequences of the hepatitis delta virus]. Mol Gen Mikrobiol Virusol 1993 0.75
68 [Hepatitis E]. Zh Mikrobiol Epidemiol Immunobiol 1997 0.75
69 [The prevalence and etiological structure of viral hepatitis in a climatic-geographic area at high risk for infection]. Zh Mikrobiol Epidemiol Immunobiol 1992 0.75
70 [Epidemiological characteristics of non-A, non-B viral hepatitis with a fecal-oral transmission mechanism]. Vopr Virusol 1986 0.75
71 [IgM- and IgG-class antibodies to the hepatitis C virus]. Vopr Virusol 1992 0.75
72 [The spread of hepatitis C markers among the population of regions of Russia and Central Asia]. Zh Mikrobiol Epidemiol Immunobiol 1994 0.75